Literature DB >> 7635987

Transcriptional induction of prostaglandin G/H synthase-2 by basic fibroblast growth factor.

H Kawaguchi1, C C Pilbeam, G Gronowicz, C Abreu, B S Fletcher, H R Herschman, L G Raisz, M M Hurley.   

Abstract

In serum-free mouse osteoblastic MC3T3-E1 cells, basic fibroblastic growth factor (bFGF) induced mRNA and protein for prostaglandin G/H synthase-2 (PGHS-2), the major enzyme in arachidonic acid (AA) conversion to prostaglandins. mRNA accumulation peaked at 1 h with bFGF 1 nM. In cells stably transfected with a 371-bp PGHS-2 promoter-luciferase reporter, bFGF stimulated luciferase activity, which peaked at 2-3 h with bFGF 1-10 nM. In the presence of exogenous AA, bFGF stimulated PGE2 production, which paralleled luciferase activity. In serum-free neonatal mouse calvarial cultures, bFGF stimulated PGE2 production in the absence of exogenous AA. bFGF stimulated PGHS-2 mRNA accumulation, which peaked at 2-4 h and then decreased; there were later mRNA elevations at 48 and 96 h that were inhibited by indomethacin. In both MC3T3-E1 cells and neonatal calvariae, bFGF produced smaller and slower increases in PGHS-1 mRNA levels than for PGHS-2. bFGF stimulated bone resorption in mouse calvariae with a maximal increase of 80% at 1 nM. Stimulation was partially inhibited by nonsteroidal anti-inflammatory drugs. We conclude that bFGF rapidly stimulates PGE2 production in osteoblasts, largely through transcriptional regulation of PGHS-2, and that prostaglandins mediate some of bFGF's effects on bone resorption.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7635987      PMCID: PMC185280          DOI: 10.1172/JCI118140

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  46 in total

1.  Transcriptional activation of c-fos and c-jun protooncogenes by serum growth factors in osteoblast-like MC3T3-E1 cells.

Authors:  R Okazaki; K Ikeda; A Sakamoto; T Nakano; K Morimoto; T Kikuchi; K Urakawa; E Ogata; T Matsumoto
Journal:  J Bone Miner Res       Date:  1992-10       Impact factor: 6.741

2.  cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase.

Authors:  M K O'Banion; V D Winn; D A Young
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

3.  Effects of acid and basic fibroblast growth factor and heparin on resorption of cultured fetal rat long bones.

Authors:  H A Simmons; L G Raisz
Journal:  J Bone Miner Res       Date:  1991-12       Impact factor: 6.741

4.  Prostaglandin E2 prevents bone loss and adds extra bone to immobilized distal femoral metaphysis in female rats.

Authors:  T Akamine; W S Jee; H Z Ke; X J Li; B Y Lin
Journal:  Bone       Date:  1992       Impact factor: 4.398

5.  Prostaglandins: stimulation of bone resorption in tissue culture.

Authors:  D C Klein; L G Raisz
Journal:  Endocrinology       Date:  1970-06       Impact factor: 4.736

6.  The interaction of heparin and basic fibroblast growth factor on collagen synthesis in 21-day fetal rat calvariae.

Authors:  M M Hurley; M Kessler; G Gronowicz; L G Raisz
Journal:  Endocrinology       Date:  1992-05       Impact factor: 4.736

7.  Effect of local prostaglandin E2 on fracture callus in rabbits.

Authors:  J Keller; A Klamer; B Bak; P Suder
Journal:  Acta Orthop Scand       Date:  1993-02

Review 8.  Prostanoid biosynthesis and mechanisms of action.

Authors:  W L Smith
Journal:  Am J Physiol       Date:  1992-08

9.  Regulation of synovial cell growth: basic fibroblast growth factor synergizes with interleukin 1 beta stimulating phospholipase A2 enzyme activity, phospholipase A2 activating protein production and release of prostaglandin E2 by rheumatoid arthritis synovial cells in culture.

Authors:  D H Goddard; S L Grossman; R Newton; M A Clark; J S Bomalaski
Journal:  Cytokine       Date:  1992-09       Impact factor: 3.861

10.  Basic fibroblast growth factor inhibits type I collagen gene expression in osteoblastic MC3T3-E1 cells.

Authors:  M M Hurley; C Abreu; J R Harrison; A C Lichtler; L G Raisz; B E Kream
Journal:  J Biol Chem       Date:  1993-03-15       Impact factor: 5.157

View more
  21 in total

Review 1.  Current insights on the regenerative potential of the periosteum: molecular, cellular, and endogenous engineering approaches.

Authors:  Céline Colnot; Xinping Zhang; Melissa L Knothe Tate
Journal:  J Orthop Res       Date:  2012-07-09       Impact factor: 3.494

2.  Treatment of experimental osteonecrosis of the hip in adult rabbits with a single local injection of recombinant human FGF-2 microspheres.

Authors:  Yutaka Kuroda; Haruhiko Akiyama; Keiichi Kawanabe; Yasuhiko Tabata; Takashi Nakamura
Journal:  J Bone Miner Metab       Date:  2010-03-31       Impact factor: 2.626

3.  Cyclo-oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants.

Authors:  M Majima; I Hayashi; M Muramatsu; J Katada; S Yamashina; M Katori
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

Review 4.  Role of heparan sulfate in ocular diseases.

Authors:  Paul J Park; Deepak Shukla
Journal:  Exp Eye Res       Date:  2013-02-11       Impact factor: 3.467

5.  Role of Rac and Cdc42 in lysophosphatidic acid-mediated cyclo-oxygenase-2 gene expression.

Authors:  Angelika Hahn; Holger Barth; Michaela Kress; Peter R Mertens; Margarete Goppelt-Struebe
Journal:  Biochem J       Date:  2002-02-15       Impact factor: 3.857

6.  Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation.

Authors:  A Montero; Y Okada; M Tomita; M Ito; H Tsurukami; T Nakamura; T Doetschman; J D Coffin; M M Hurley
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

7.  Regulatory role of prostaglandin E2 in induction of cyclo-oxygenase-2 by a thromboxane A2 analogue (U46619) and basic fibroblast growth factor in porcine aortic smooth-muscle cells.

Authors:  S Karim; E Berrou; S Lévy-Toledano; M Bryckaert; J MacLouf
Journal:  Biochem J       Date:  1997-09-01       Impact factor: 3.857

8.  Complement C5b-9-mediated arachidonic acid metabolism in glomerular epithelial cells : role of cyclooxygenase-1 and -2.

Authors:  T Takano; A V Cybulsky
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

9.  Corticosteroids induce cyclooxygenase 1 expression in cardiomyocytes: role of glucocorticoid receptor and Sp3 transcription factor.

Authors:  Haipeng Sun; Elena Sheveleva; Qin M Chen
Journal:  Mol Endocrinol       Date:  2008-07-03

10.  In vitro and in vivo evidence for stimulation of bone resorption by an EP4 receptor agonist and basic fibroblast growth factor: Implications for their efficacy as bone anabolic agents.

Authors:  M E Downey; L S Holliday; J I Aguirre; T J Wronski
Journal:  Bone       Date:  2008-10-25       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.